A long‐term, randomized, comparative study of insulin versus sulfonylurea therapy in type 2 diabetes

Abstract

Insulin therapy was superior to SU treatment in achieving good metabolic control. Despite a modest improvement in cardiovascular risk factors in the insulin-treated group, no significant differences were observed between the groups after 1 year's treatment.